drug

anacaulase-bcdb

1 story · latest Jul 30, 2026

Status: FDA approved Dec 2022 · BLA761192
Brand: Nexobrid

Relationships

Developed by Vericel Corporation

Timeline

Vericel raises 2026 revenue guidance, launches $200 million buyback

Jul 30Quarterly updateMaci Vericel Corporation

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.